BOSTON SCIENTIFIC CORP — Director's Dealing 2015

Mar 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-02-27

Reporting Person: Pierce David A (SVP and President, Endoscopy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-27	Common Stock	S	19046.0000	$16.8043	Disposed	28161.0000	Direct

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan.